Medical Device Law Weekly

Biophan Technologies, Inc. - Licensing agreements cover use of technologies for MRI safety

Boston Medical Center - Growth hormone is illegal for off-label anti-aging use

Kuopio University Hospital - Findings advance knowledge in imaging research

University of Zurich Hospital - Contrast-enhanced CT and PET/CT recommended for diagnosing oral cavity carcinoma

VNUS Medical Technologies, Inc. - Devices company reports patent lawsuits against AngioDynamics, Vascular Solutions

Yale University - Prior aspirin use is not a marker of increased mortality in elderly patients with acute MI

Aachen University of Technology - Researchers' work adds to imaging body of knowledge

Aaron Diamond AIDS Research Center, New York - Abacavir/lamivudine/zidovudine improves HAART adherence in HIV-1-infected patients

Albert Einstein College of Medicine, Hyde Park - Meprin-alpha appears to play a role in chronic diabetic nephropathy

Alexandra University Hospital - Intima-media thickness score from carotid and femoral arteries predicts extent of CAD

Alfacell Corporation - New research shows Onconase inhibits tumor growth in non-small cell lung cancer

Alliance Pharma plc - Hygroton maker appoints new director of regulatory affairs

Ankara Education and Research Hospital - Complex regional pain syndrome type I reported after rubella vaccine

Annamalai University -  Cuminum cyminum decreases lipid levels in alcohol and oxidized oil induced toxicity

Antares Pharma, Inc. - Stockholder of drug delivery devices company provides $4 million credit line

Antigenics, Inc. - Jill M. Forrest named VP of marketing and sales at immunotherapeutics company

Aprogen Inc. - Monoclonal antibody protects against anthrax toxin

Association for the Accreditation of Human Research Protection Programs - Regulatory exemptions for humans in radiology research outlined

Athenagen, Inc. - Henry Hsu appointed as chief medical officer at company developing anti-angiogenesis drugs

Barbara Ann Karmanos Cancer Institute, Detroit - Target suppression and antitumor activity of MEK inhibitor CI-1040 demonstrated

Barr Pharmaceuticals, Inc. - Duramed to acquire FEI Women's Health and its ParaGard IUD product

Baxter Healthcare Corp. - U.S. FDA approves Flexbumin, an albumin solution, in a flexible container

Baylor College of Medicine - Discovery provides new clues about causes of Rett syndrome

Baylor College of Medicine, Houston - Ankle-brachial index predicts asymptomatic peripheral arterial disease

Baylor College of Medicine, Houston - Biology of osteogenic sarcoma discussed

Baylor College of Medicine, Houston - HIV protease inhibitor ritonavir increases endothelial monolayer permeability

Berufsgenossenschaftliche Unfallklin, Tubingen - Matrix-assisted autologous chondrocyte transplantation improves previous methods